DCLK1 and neoplasm: Furthermore, miR-15b overexpression suppressed tumorigenic properties of tumour-initiating cells and restored sensitivity to adjuvant chemotherapy and neoadjuvant radiotherapy in CRC patients by targeting doublecortin-like kinase 1 (DCLK1), a putative gastrointestinal stem cell marker [189].